Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 2/2014

01-02-2014 | Original Article

Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume

Authors: Elenir B. C. Avritscher, Catherine D. Cooksley, Kenneth V. Rolston, J. Michael Swint, George L. Delclos, Luisa Franzini, Stephen G. Swisher, Garrett L. Walsh, Paul F. Mansfield, Linda S. Elting

Published in: Supportive Care in Cancer | Issue 2/2014

Login to get access

Abstract

Purpose

Unlike infections related to chemotherapy-induced neutropenia, postoperative infections occurring in patients with solid malignancy remain largely understudied. Our aim is to evaluate the outcomes and the volume–outcomes relationship associated with postoperative infections following resection of common solid tumors.

Methods

We used Texas Discharge Data to study patients undergoing resection of cancer of the lung, esophagus, stomach, pancreas, colon, or rectum from 01/2002 to 11/2006. From their billing records, we identified ICD-9 codes indicating a diagnosis of serious postoperative infection (SPI), i.e., bacteremia/sepsis, pneumonia, and wound infection, occurring during surgical admission or leading to readmission within 30 days of surgery. Using regression-based techniques, we estimated the impact of SPI on mortality, resource utilization, and costs, as well as the relationship between hospital volume and SPI, after adjusting for confounders and data clustering.

Results

SPI occurred following 9.4 % of the 37,582 eligible tumor resections and was independently associated with nearly 12-fold increased odds of in-hospital mortality [95 % confidence interval (95 % CI), 7.2–19.5, P < 0.001]. Patients with SPI required six additional hospital days (95 % CI, 5.9–6.2) at an incremental cost of $16,991 (95 % CI, $16,495–$17,497). Patients who underwent resection at high-volume hospitals had a 16 % decreased odds of developing SPI than those at low-volume hospitals (P = 0.03).

Conclusions

Due to the substantial burden associated with SPI following common solid tumor resections, hospitals must identify more effective prophylactic measures to avert these potentially preventable infections. Additional volume–outcomes research is needed to identify infection prevention processes that can be transferred from high- to lower-volume providers.
Literature
1.
Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP et al (2007) Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 122:160–166PubMedCentralPubMed
2.
3.
Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence—SEER 9 Regs Limited-Use, Nov 2007 Sub (1973–2005) <Katrina/Rita Population Adjustment>—Linked To County Attributes—Total U.S., 1969–2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission
4.
Department of Health and Human Services, Centers for Medicare and Medicaid Services (2001) Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2002 rates; final rule. Fed Regist 66:39827–40102
5.
Department of Health and Human Services, Centers for Medicare and Medicaid Services (2003) Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2003 rates; final rule. Fed Regist 67:49982–50289
6.
Department of Health and Human Services, Centers for Medicare and Medicaid Services (2003) Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2004 rates; final rule. Fed Regist 68:45345–45672
7.
Department of Health and Human Services, Centers for Medicare and Medicaid Services (2004) Medicare Program; changes to the hospital inpatient prospective payment systems and fiscal year 2005 rates; final rule. Fed Regist 69:48916–48964
8.
Department of Health and Human Services, Centers for Medicare and Medicaid Services (2005) Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2006 rates; final rule. Fed Regist 70:47278–47707
9.
10.
Birkmeyer JD, Sun Y, Goldfaden A, Birkmeyer NJ, Stukel TA (2006) Volume and process of care in high-risk cancer surgery. Cancer 106:2476–2481PubMedCrossRef
11.
12.
Bagger JP, Zindrou D, Taylor KM (2004) Postoperative infection with methicillin-resistant Staphylococcus aureus and socioeconomic background. Lancet 363:706–708PubMedCrossRef
13.
Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK et al (1996) Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 335:791–799PubMedCrossRef
14.
Krieger N (1992) Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82:703–710PubMedCrossRef
15.
16.
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383PubMedCrossRef
17.
Iezzoni LI, Foley SM, Heeren T, Daley J, Duncan CC et al (1992) A method for screening the quality of hospital care using administrative data: preliminary validation results. QRB Qual Rev Bull 18:361–371PubMed
18.
Romano PS, Roos LL, Jollis JG (1993) Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 46:1075–1079, discussion 1081–1090PubMedCrossRef
19.
Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH et al (2000) Identification of in-hospital complications from claims data. Is it valid? Med Care 38:785–795PubMedCrossRef
20.
McCarthy EP, Iezzoni LI, Davis RB, Palmer RH, Cahalane M et al (2000) Does clinical evidence support ICD-9-CM diagnosis coding of complications? Med Care 38:868–876PubMedCrossRef
21.
Romano PS, Chan BK, Schembri ME, Rainwater JA (2002) Can administrative data be used to compare postoperative complication rates across hospitals? Med Care 40:856–867PubMedCrossRef
22.
Rosen AK, Geraci JM, Ash AS, McNiff KJ, Moskowitz MA (1992) Postoperative adverse events of common surgical procedures in the Medicare population. Med Care 30:753–765PubMedCrossRef
23.
24.
25.
Manning WG, Basu A, Mullahy J (2005) Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 24:465–488PubMedCrossRef
26.
Roberts RR, Scott RD 2nd, Cordell R, Solomon SL, Steele L et al (2003) The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clin Infect Dis 36:1424–1432PubMedCrossRef
27.
Haley RW, White JW, Culver DH, Hughes JM (1987) The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system. An empirical determination from a nationally representative sample. JAMA 257:1611–1614PubMedCrossRef
28.
Haley RW, Culver DH, White JW, Morgan WM, Emori TG et al (1985) The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121:182–205PubMed
29.
Harbarth S, Sax H, Gastmeier P (2003) The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 54:258–266, quiz 321PubMedCrossRef
30.
Anderson DJ, Hartwig MG, Pappas T, Sexton DJ, Kanafani ZA et al (2008) Surgical volume and the risk of surgical site infection in community hospitals: size matters. Ann Surg 247:343–349PubMedCrossRef
31.
Farber BF, Kaiser DL, Wenzel RP (1981) Relation between surgical volume and incidence of postoperative wound infection. N Engl J Med 305:200–204PubMedCrossRef
32.
Muilwijk J, van den Hof S, Wille JC (2007) Associations between surgical site infection risk and hospital operation volume and surgeon operation volume among hospitals in the Dutch nosocomial infection surveillance network. Infect Control Hosp Epidemiol 28:557–563PubMedCrossRef
33.
Wu SC, Chen CC, Ng YY, Chu HF (2006) The relationship between surgical site infection and volume of coronary artery bypass graft surgeries: Taiwan experience. Infect Control Hosp Epidemiol 27:308–311PubMedCrossRef
34.
Thompson DA, Makary MA, Dorman T, Pronovost PJ (2006) Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg 243:547–552PubMedCrossRef
35.
Jarvis WR (1996) Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 17:552–557PubMedCrossRef
36.
Zhan C, Miller MR (2003) Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 290:1868–1874PubMedCrossRef
37.
Digiovine B, Chenoweth C, Watts C, Higgins M (1999) The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160:976–981PubMedCrossRef
38.
Haley RW, Culver DH, White JW, Morgan WM, Emori TG (1985) The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol 121:159–167PubMed
39.
Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP (1989) Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 129:1258–1267PubMed
40.
Akiyoshi T, Ueno M, Fukunaga Y, Nagayama S, Fujimoto Y, Konishi T, Kuroyanagi H, Yamaguchi T (2011) Effect of body mass index on short-term outcomes of patients undergoing laparoscopic resection for colorectal cancer: a single institution experience in Japan. Surg Laparosc Endosc Percutan Tech 21(6):409–414PubMedCrossRef
41.
Vogel TR, Dombrovskiy VY, Lowry SF (2010) In-hospital delay of elective surgery for high volume procedures: the impact on infectious complications. J Am Coll Surg 211(6):784–790PubMedCentralPubMedCrossRef
Metadata
Title
Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume
Authors
Elenir B. C. Avritscher
Catherine D. Cooksley
Kenneth V. Rolston
J. Michael Swint
George L. Delclos
Luisa Franzini
Stephen G. Swisher
Garrett L. Walsh
Paul F. Mansfield
Linda S. Elting
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-2006-1

Other articles of this Issue 2/2014

Supportive Care in Cancer 2/2014 Go to the issue

Letter to the editor

Effects of telemonitoring in cancer patients

Original Article

Depression and family interaction among low-income, predominantly hispanic cancer patients: a longitudinal analysis

Original Article

Fast-track surgery improves postoperative clinical recovery and reduces postoperative insulin resistance after esophagectomy for esophageal cancer

Original Article

A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer

Original Article

The role of interpersonal relationships in men's attendance in primary care: qualitative findings in a cohort of men with prostate cancer

Review Article

Social competence in pediatric brain tumor survivors: evaluating the psychometric properties of assessment tools
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits